On August 26, Everpure rose 5.04% in regular trading, trading at $108.07/share, with turnover of $72.58 million.

On the news front, Everpure is set to report fiscal Q2 2027 results after market close today, with Wall Street consensus expecting revenue of approximately $1.1 billion, representing roughly 30% year-over-year growth, and adjusted earnings per share of $0.58, up nearly 50% year-over-year. Wedbush expects a beat-and-raise quarter, citing stronger pricing, favorable product mix, and steady demand, while raising its price target to $127 from $105 and maintaining an Outperform rating. Susquehanna upgraded the stock to Positive with a target of $120, and Morgan Stanley upgraded to Overweight with a $108 target. Additionally, the company recently secured a second design and supply agreement with an undisclosed top-five hyperscaler, expected to become a significant revenue contributor starting in fiscal 2028, further reinforcing confidence in the company's long-term growth trajectory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)